A Study of Changes to Prostate Procedures
NCT06986083 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 800
Last updated 2026-05-22
Summary
The purpose of this study is to look whether using local anesthesia during a transperineal prostate biopsy, while put to sleep by IV sedation, helps reduce the number of people who feel significant pain in the recovery room. The researchers will also look at how local anesthesia affects the amount of pain medication used, how quickly people can go home after the biopsy, and how well they recover after leaving the hospital.
Conditions
Interventions
- PROCEDURE
-
Prostate Biopsy
Transperineal prostate biopsy
- DRUG
-
Local anesthesia
Local anesthesia in addition to IV sedation
Sponsors & Collaborators
-
Memorial Sloan Kettering Cancer Center
lead OTHER
Principal Investigators
-
Jonathan Fainberg, MD, MPH · Memorial Sloan Kettering Cancer Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-05-19
- Primary Completion
- 2028-05-31
- Completion
- 2028-05-31
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Studying Stored Samples From Patients With Localized Prostate Cancer Treated on Clinical Trial NCI-00-C-0154
NCT00535834 ·Status: COMPLETED
-
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection
NCT06849544 ·Status: RECRUITING ·Phase: PHASE2
-
Prostate Cancer - Comparative Outcomes of New Conceptual Paradigms for Treatment
NCT04890314 ·Status: COMPLETED
-
Study of How People Make Decisions About Prostate Cancer Risk
NCT07197723 ·Status: RECRUITING
-
Liquid Biopsy-based Detection of Resistance to Targeted Therapy in Prostate Cancer Patients
NCT03601143 ·Status: UNKNOWN
-
Effect of Androgen Suppression on Bone Loss in Patients With or Without Bone Metastases Secondary to Prostate Cancer
NCT00003903 ·Status: COMPLETED ·Phase: NA
-
Fractionated and Multiple Dose 225Ac-J591 for Progressive mCRPC
NCT04506567 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Androgen Ablation Therapy With or Without Vaccine Therapy in Treating Patients With Prostate Cancer
NCT00771017 ·Status: WITHDRAWN ·Phase: PHASE2
-
GZ17-6.02 in Advanced CRPC After Progression on Anti-Androgen Therapy
NCT06636123 ·Status: RECRUITING ·Phase: PHASE1
-
Evaluation of Lithium and It's Effect on Clinically Localized Prostate Cancer
NCT02198859 ·Status: COMPLETED ·Phase: PHASE1
-
Effectiveness, Safety, and Economic Evaluation of Goserelin Microspheres for Injection and Goserelin Sustained-Release Implants in Prostate Cancer Patients: A Real-World Study
NCT06929884 ·Status: ACTIVE_NOT_RECRUITING
-
Phase 2 Study of G-202 in Patients With Chemotherapy-Naïve Metastatic Castrate-Resistant Prostate Cancer
NCT01734681 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)
NCT00028353 ·Status: COMPLETED ·Phase: PHASE2
-
Oral Colchicine in Men With Castrate Resistant Prostate Cancer
NCT01481233 ·Status: WITHDRAWN ·Phase: PHASE2
-
Impact of PSA-based Screening on Mortality Among Men Aged 75-79: Target Trial Emulation
NCT07206693 ·Status: COMPLETED
-
Clinical Study of SU011248 in Subjects With High Risk Prostate Cancer Who Have Elected to Undergo Radical Prostatectomy
NCT00790595 ·Status: COMPLETED ·Phase: PHASE1
-
Surgery in Treating Patients With Prostate Cancer
NCT00002938 ·Status: COMPLETED ·Phase: PHASE2
-
A SHR3680 QT/QTc Study on Castration-Resistant Prostate Cancer Subjects
NCT05607693 ·Status: UNKNOWN ·Phase: PHASE1
-
Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer
NCT00017563 ·Status: COMPLETED ·Phase: PHASE2
-
Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer
NCT06145633 ·Status: RECRUITING ·Phase: PHASE2
-
Prostate-specific Membrane Antigen Antibody-Drug Conjugate in Subjects With Prostate Cancer
NCT01414283 ·Status: COMPLETED ·Phase: PHASE1
-
Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Cell Vaccines (Allogeneic Prostate GVAX®)
NCT00140387 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Effect of Androgen Deprivation Therapy on Cardiovascular Function in Prostate Cancer
NCT03275181 ·Status: COMPLETED
-
Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer
NCT00052481 ·Status: COMPLETED
-
Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)
NCT00106691 ·Status: COMPLETED ·Phase: PHASE3